BD MAX CTGCTV2, BD MAX System— 510(k) K182692

Substantially Equivalent

Becton, Dickinson and Company

FDA 510(k) clearance K182692 for BD MAX CTGCTV2, BD MAX System, Substantially Equivalent on 2019-01-08. Applicant: Becton, Dickinson and Company.

Clearance details

Applicant
Becton, Dickinson and Company
Product code
Code OUY
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Sparks, MD, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.